Ledger.Open graph →
SEC Form D · filed February 18, 2021

Saliogen Therapeutics, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BURLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Sukumar Nagendran · Cambridge, MADirectorJoseph Higgins · Burlington, MAExec · DirectorRaymond Tabibiazar · Burlington, MAExec · DirectorSean Stalfort · San Carlos, CADirectorSukumar Nagendran · Burlington, MADirectorSean Stalfort · San Carlos, CADirectorJoseph Higgins · Burlington, MAExec · DirectorRaymond Tabibiazar · Burlington, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗